Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer

Clinical pharmacology and therapeutics

Volumn 96, Issue 5, 2014, Pages 609-615

  Pu, X ^a   Wang, L ^a   Chang, J Y ^a   Hildebrandt, M A T ^a   Ye, Y ^a   Lu, C ^a   Skinner, H D ^a   Niu, N ^a   Jenkins, G D ^a   Komaki, R ^a   Minna, J D ^a   Roth, J A ^a   Weinshilboum, R M ^a   Wu, X ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMPLICATION; FEMALE; GENETIC VARIABILITY; GENETICS; HUMAN; INFLAMMATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION DOSE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENETIC VARIATION; HUMANS; INFLAMMATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION TOLERANCE; RADIOTHERAPY;

EID: 84924926212     PISSN: None     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2014.154     Document Type: Article

References (0)